
Work Here?
Seqera Labs provides software to orchestrate data analysis pipelines in genomics and life sciences. Built on Nextflow, Seqera Tower adds enterprise features for collaboration, monitoring, and deploying pipelines at scale on premises or in the cloud. It differentiates by offering an enterprise-grade runtime layer on top of the open-source Nextflow core, focusing on governance, scalability, and collaboration for pharma, biotech, and genomics teams. The goal is to help researchers accelerate genomic data analysis and drug discovery, enabling faster public health responses and more efficient scientific workflows across large organizations.
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$29.8M
Headquarters
Barcelona, Spain
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$29.8M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Health Insurance
Private health insurance
Wellness Program
Mental Health Support
Home Office Stipend
Learning and development budget per year (1,000 USD)
Unlimited Paid Time Off
Flexible Work Hours
Hybrid Work Options
Benchling utilizes Model Context Protocol to bridge scientific data with AI ecosystems. Published. April 30, 2026 Benchling has launched AI Connectors, a new integration suite built on the Model Context Protocol (MCP) designed to unify fragmented scientific and enterprise data streams. The platform, which supports over 1,300 biotech organizations including Merck and Moderna, aims to eliminate the manual "copy-paste" workflows that currently plague R&D. By establishing a standardized interface, the connectors allow researchers to pull context directly from institutional tools like SharePoint, Snowflake, and Notion into their experimental records. This bidirectional data flow ensures that AI agents can access the full breadth of a project's history - ranging from experiment records to internal institutional knowledge - without losing critical scientific context. The new capabilities also extend to specialized research tools, allowing scientists to query a deep index of over 8 million biomedical papers via Elicit and GXL without leaving their digital notebooks. Furthermore, the Benchling MCP Server enables external AI models, such as Claude and ChatGPT, to query structured laboratory records directly, providing researchers with answers grounded in verified experimental data. By integrating bioinformatics workflows from Seqera and large datasets via Amazon S3, the update seeks to turn Benchling into a centralized hub for the entire R&D lifecycle. Following a successful beta phase, the company expects general availability of the full MCP offering in May 2026.
Seqera acquires Tinybio to democratize access to ai-powered bioinformatics.
Seqera has acquired Tinybio, a tech-bio startup specializing in AI-powered bioinformatics tools, to enhance its scientific data analysis platform. The acquisition aims to democratize access to advanced bioinformatics through natural language processing and user-friendly interfaces. Tinybio’s founders, CEO Sasha Dagayev and CTO Vishal Patel, will collaborate with Seqera to advance open-source software and scientific progress. Financial details were not disclosed.
In 2020, Seqera launched Seqera Platform (formerly Nextflow Tower), a centralized command post for Nextflow pipelines.
BARCELONA, Spain, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Seqera, the leading software provider for complex data analysis in the life sciences space, has been confirmed as the official High Performance Computing Supplier for Alinghi Red Bull Racing at the 37 America's Cup.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$29.8M
Headquarters
Barcelona, Spain
Founded
2018
Find jobs on Simplify and start your career today